• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Reduce crushing costs

Article

Better management of chronic conditions will be critical to the future of healthcare delivery, according to Tracey Moorhead.

"Certainly having more people with healthcare coverage is going to help keep costs down in one regard, but better management of chronic conditions and prevention of chronic conditions will be crucial to the future of healthcare delivery," Moorhead says. "There are a number of things that are coming together to do that. One is better reimbursement for those types of services. Another is expansion of the healthcare team beyond just the physician."

DMAA advances the emerging population-health-management (PHM) model, which expands on the traditional practice of disease management, reaching out to a broader range of individuals and intervening earlier to prevent or reduce disease-and the associated profit-crushing costs. Delivered through a variety of outreach techniques across the whole spectrum of care, PHM combines prevention and management to create a recipe for bending the cost curve, she says.

DMAA, based in Washington, D.C., is the industry's resource center of population health management strategies. Its 200 members include health plans, employers, government programs and agencies, carve-outs, providers and researchers. Conducting its own original research, DMAA collaborates on industry standards and makes national policy recommendations.

Related Videos
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 8 - "Demographic Differences That Impact Care"
Related Content
© 2024 MJH Life Sciences

All rights reserved.